Literature DB >> 19377056

Detection of the hepatitis C virus antigen in kidney tissue from infected patients with various glomerulonephritis.

Yali Cao1, Youkang Zhang, Suxia Wang, Wanzhong Zou.   

Abstract

BACKGROUND: Several studies have postulated a causal link between hepatitis C virus (HCV) infection and renal diseases through the induction of cryoglobulinaemia. However, the detection of viral antigens within kidneys of HCV-infected patients has proved to be difficult. We studied a cohort of Chinese HCV-infected patients with various glomerulonephritis (GN) in an attempt to detect HCV antigens within their kidneys.
METHODS: Twenty-one patients with various GN were found to be serum HCV-antibody positive (seven serum HCV-RNA positive simultaneously), at the time of renal biopsy, from January 2005 to April 2008 in our hospital. A murine monoclonal antibody against the HCV-NS3 protein was employed to detect the HCV antigen using immunohistochemistry and immunogold labelling. Their clinical and pathological data were collected and further analysed.
RESULTS: The HCV-NS3 antigen was detected in six (6/21, 28.6%) HCV-antibody-positive patients by immunohistochemistry and four out of the six were serum HCV-RNA positive (4/7 in HCV-RNA positive, 57.1%). The HCV antigen mainly displayed a linear or granular deposition along glomerular capillary walls and/or mesangial region. Immunoelectron microscopy showed that the labelling of HCV-NS3 was localized mainly in electronic dense deposits. In the HCV-NS3 detectable patients, three patients were with membranoproliferative glomerulonephritis (MPGN), one with membranous nephropathy, one with IgA nephropathy and one with amyloid nephropathy. The age and urinary protein were significantly greater in HCV-NS3-positive patients than those in HCV-NS3 negative, while serum C3 level was significantly lower in the former group. No significant difference was found in serum ALT, albumin and creatinine level between the two groups.
CONCLUSION: HCV-NS3 antigens could be detected in kidney tissue of HCV-infected patients with various GN, but mainly in those with MPGN and HCV-RNA positive. HCV itself might be involved directly in the pathogenesis of HCV-associated GN.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19377056     DOI: 10.1093/ndt/gfp167

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  11 in total

Review 1.  Hepatitis C and kidney disease: An overview and approach to management.

Authors:  Ahmad Najib Azmi; Soek-Siam Tan; Rosmawati Mohamed
Journal:  World J Hepatol       Date:  2015-01-27

2.  Higher prevalence of chronic kidney disease and shorter renal survival in patients with chronic hepatitis C virus infection.

Authors:  Sanjaya Kumar Satapathy; Chandra Sekhar Lingisetty; Susan Williams
Journal:  Hepatol Int       Date:  2011-06-23       Impact factor: 6.047

3.  Risk of kidney cancer and chronic kidney disease in relation to hepatitis C virus infection: a nationwide register-based cohort study in Sweden.

Authors:  Jonathan N Hofmann; Anna Törner; Wong-Ho Chow; Weimin Ye; Mark P Purdue; Ann-Sofi Duberg
Journal:  Eur J Cancer Prev       Date:  2011-07       Impact factor: 2.497

4.  A case of monoclonal immunoglobulin G1-lambda deposition associated with membranous feature in a patient with hepatitis C viral infection.

Authors:  Takehisa Yamada; Yusuke Arakawa; Akiko Mii; Tetsuya Kashiwagi; Tomohiro Kaneko; Koichi Utsumi; Yukinari Masuda; Akira Shimizu; Yasuhiko Iino; Yasuo Katayama
Journal:  Clin Exp Nephrol       Date:  2012-01-19       Impact factor: 2.801

5.  Sofosbuvir and ledipasvir decreased nephrotic syndrome caused by IgA nephropathy with a membranoproliferative pattern of injury in hepatitis C virus-induced cirrhosis: a case report.

Authors:  Xiaohao Zhang; Jing Zhou; Canming Li; Jialing Rao; Yuanqing Li; Jun Zhang; Hui Peng
Journal:  Ann Transl Med       Date:  2022-04

6.  Collapsing glomerulopathy after hepatitis C pegylated interferon treatment. Recovery of renal function with high-dose steroid treatment.

Authors:  Roberto H Berdichevski; Eduardo M De Carvalho; Maria Isabel Edelweiss; Luiz Felipe Gonçalves; Roberto C Manfro
Journal:  NDT Plus       Date:  2010-08-24

Review 7.  Hepatitis C and kidney disease: A narrative review.

Authors:  Rashad S Barsoum; Emad A William; Soha S Khalil
Journal:  J Adv Res       Date:  2016-07-26       Impact factor: 10.479

8.  De Novo Fibrillary Glomerulonephritis (FGN) in a Renal Transplant with Chronic Hepatitis C.

Authors:  Edward J Filippone; Christine Chmielewski; Rakesh Gulati; Eric Newman; John L Farber
Journal:  Case Rep Transplant       Date:  2013-06-13

Review 9.  Molecular signature in HCV-positive lymphomas.

Authors:  Valli De Re; Laura Caggiari; Marica Garziera; Mariangela De Zorzi; Ombretta Repetto
Journal:  Clin Dev Immunol       Date:  2012-08-16

10.  Significance of monoclonal antibodies against the conserved epitopes within non-structural protein 3 helicase of hepatitis C virus.

Authors:  Yixin Bian; Shuoxian Zhao; Shaomei Zhu; Jinfeng Zeng; Tingting Li; Yongshui Fu; Yuanzhan Wang; Xin Zheng; Ling Zhang; Wenjing Wang; Baocheng Yang; Yuanping Zhou; Jean-Pierre Allain; Chengyao Li
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.